SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Equities researchers at Stifel Canada lifted their FY2025 earnings per share (EPS) estimates for shares of SNC-Lavalin Group in a research report issued to clients and investors on Sunday, October 5th. Stifel Canada analyst I. Gillies now forecasts that the company will post earnings per share of $3.32 for the year, up from their prior forecast of $3.28.
Separately, National Bank Financial lowered shares of SNC-Lavalin Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, June 11th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy”.
SNC-Lavalin Group Price Performance
SNC-Lavalin Group Company Profile
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
Featured Stories
- Five stocks we like better than SNC-Lavalin Group
- What is diluted earnings per share (Diluted EPS)?
- 2 Defense Stocks Riding 2025’s Massive Momentum Wave
- Pros And Cons Of Monthly Dividend Stocks
- TrumpRx Brings Pfizer Into the Green—Is It a Buy?
- How to Calculate Options Profits
- Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
